Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics
Open Access
- 1 November 1998
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 34 (12), 1922-1926
- https://doi.org/10.1016/s0959-8049(98)00288-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Early detection of familial ovarian cancerEuropean Journal Of Cancer, 1996
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: The dutch experience on 24 families under surveillanceEuropean Journal Of Cancer, 1993
- Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.BMJ, 1993
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990